Around 20.13% of the Hungarian citizens (based on the 2011 census [1][2] and the official vaccination statistics) have received, at least, one anti-COVID-19 injection, since 28 March 2021.
Reports in March 2021 stated that Hungary was the first country in the EU to "begin using China's Sinopharm BIBP and Russia's Sputnik V vaccines, even as polling showed that public trust in non-EU approved vaccines was low".
One suggestion to resolve that issue was that "Russian and Chinese vaccine producers submit their products to the EMA for testing and authorization".
[6][7] A consortium founded by the Department of Immunology at the Faculty of Sciences of Eötvös Loránd University, the Institute of Biology at the Science Faculty of the University of Pécs, Richter Gedeon and ImmunoGenes is involved in international biotechnological developments.
[8][9] Imre Kacskovics, leader of Immunology Department of ELTE, said the product currently in the first phase of development won't be a vaccine, but provide passive immunity.